Author response: Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors

MLA

Lisa Goebel, et al. Author Response: Targeting Oncogenic KRasG13C with Nucleotide-Based Covalent Inhibitors. Feb. 2023. EBSCOhost, https://doi.org/10.7554/elife.82184.sa2.

APA

Lisa Goebel, Tonia Kirschner, Sandra Koska, Amrita Rai, Petra Janning, Stefano Maffini, Helge Vatheuer, Paul Czodrowski, Roger S Goody, Matthias P Müller, & Daniel Rauh. (2023). Author response: Targeting oncogenic KRasG13C with nucleotide-based covalent inhibitors. https://doi.org/10.7554/elife.82184.sa2

Chicago

Lisa Goebel, Tonia Kirschner, Sandra Koska, Amrita Rai, Petra Janning, Stefano Maffini, Helge Vatheuer, et al. 2023. “Author Response: Targeting Oncogenic KRasG13C with Nucleotide-Based Covalent Inhibitors,” February. doi:10.7554/elife.82184.sa2.